Professor, Pediatrics, Medical College of Wisconsin
Pediatric Hematology & Oncology
Dr. Joan C. Gill, MD
|
|
Give Review
Doctor Joan C. Gill, MD is an expert in the field of Pediatric Hematology & Oncology. She attended Medical College of Wisconsin. Medical College of Wisconsin is ranked 54/62 in Research/PrimaryCare. She over the years received 1 awards: "Super Doctor". Joan Gill is a published physician as well. She has 83 publications published. The latest was: Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Publications
- Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
- Rapid discrimination of the phenotypic variants of von Willebrand Disease.
- Hemostatic efficacy, safety and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand Disease.
- Thrombolysis in pediatric stroke study.
- Crucial role for the VWF A1 domain in binding to type IV collagen.
- Changes in bleeding patterns in von Willebrand Disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
- Neonatal circumcision in severe haemophilia: a survey of paediatric haematologists at United States Hemophilia Treatment Centers.
- Thromboembolic incidence with transiently elevated levels of Coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surg...
- Emergence of the Primary Pediatric Stroke Center: Impact of the Thrombolysis in Pediatric Stroke Trial.
- Rituximab for treatment of inhibitors in haemophilia A. A Phase II Study.
- Diagnosis of von Willebrand Disease in people with type o blood.
- Approach to acute ischemic stroke in childhood.
- Desmopressin (DDAVP) in the management of patients with congenital bleeding Disorders.
- No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
- Variability in Platelet- and collagen-binding defects in type 2M von Willebrand disease.
- The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.
- Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors.
- Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease.
- Thromboelastography in the assessment of bleeding following surgery for congenital heart Disease.
- Von Willebrand factor mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
- Von Willebrand disease in the United States: a perspective from wisconsin.
- Naturally occurring CD4(+) T-Cell epitope variants act as altered peptide ligands leading to impaired helper T-Cell responses in hepatitis C virus infection.
- Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
- Pharmacology in childhood arterial ischemic stroke.
- Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
- Eptifibatide-induced thrombocytopenia and Thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
- Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human Platelets.
- Treatment of urgent bleeding in von Willebrand Disease.
- Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand Disease with decreased VWF survival.
- Genetic mutations in von Willebrand Disease identified by DHPLC and DNA sequence analysis.
- Preventing excessive bleeding in patients with von Willebrand Disease.
- Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild Hemophilia A or mild-to-moderate type 1 von Willebrand disease.
- Natural history and therapy of hepatitis B and C in patients with HIV Disease.
- Failure of fresh frozen plasma infusions to alter the course of hemolytic uremic Syndrome.
- Childhood stroke and lupus anticoagulant.
- An unusual cause of cerebral Venous thrombosis in a four-year-old child.
- Prepooled cryoprecipitate for treatment of Hemophilia A.
- Long-term follow-up of Hemophiliacs with lymphocytopenia or thrombocytopenia.
- Induction of immune tolerance in a 7-year-old Hemophiliac with an anaphylactoid inhibitor.
- Increased incidence of HLA-B40 group antigens in children with hemolytic-uremic Syndrome.
- High-dose intravenous gamma globulin infusions in hemolytic-uremic Syndrome: a preliminary report.
- Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric Coagulation consortium study.
- T-lymphocyte subpopulations in patients with classic Hemophilia treated with cryoprecipitate and lyophilized concentrates.
- AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in Hemophiliacs. Hemophilia Malignancy Study Group.
- Reversal of central nervous system involvement in hemolytic uremic Syndrome by use of plasma exchanges.
- Computerized tomography in Hemophiliacs with head trauma.
- Therapy of factor VIII deficiency.
- Newborn haemostasis.
- Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous Sickle cell disease.
- Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
- A naturally occurring, warm-reactive macroglobulin specific for papain-treated human Platelets: preliminary characterization.
- Low-molecular-weight heparin in thrombotic Disease in children and adolescents.
- Persistence and progression of immunologic abnormalities in haemophilia.
- Generalized lymphadenopathy and T cell abnormalities in Hemophilia A.
- Hepatitis C virus: models of immunopathogenesis and prophylaxis.
- Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired Hemophilia patients.
- The role of genetics in inhibitor formation.
- The effect of ABO blood group on the diagnosis of von Willebrand Disease.
- Heparin-induced thrombocytopenia in a child.
- Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Ha...
- HTLV-III serology in Hemophilia: relationship with immunologic abnormalities.
- Molecular basis of human von Willebrand disease: analysis of Platelet von Willebrand factor mRNA.
- Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac Defects.
- Bleeding Disorders: A common cause of menorrhagia in adolescents.
- The critical interaction of glycoprotein (GP) IBbeta with GPIX-a genetic cause of Bernard-Soulier Syndrome.
- Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand Disease (type 3 VWD): estimation of the rate of factor VIIIC synthesi...
- Interferon-gamma secretion Defects in haemophilia A patients receiving highly purified plasma-derived or recombinant factor VIII.
- von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand Disease.
- B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-w...
- Successful treatment for patients with von Willebrand Disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P).
- Glanzmann Thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminu...
- Interactions between von Willebrand factor and Factor VIII: where did they first meet.
- Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T Cells in HCV infection.
- Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage.
- Successful treatment of urgent bleeding in von Willebrand Disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measur...
- Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
- Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
- Type 2M:Milwaukee-1 von Willebrand Disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Wille...
- Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of ...
- Hepatitis C virus induces regulatory T Cells by naturally occurring viral variants to suppress T Cell responses.
- The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand Disease. Results from a p...
- Epitopes of the NS3 protein of hepatitis C virus: recognition in HLA-DR4 transgenic mice.
Schools
Medical College of Wisconsin
Milwaukee Chldns HospMed C
Conditions Treated
- Anemia
- Antiphospholipid Syndrome (APS)
- Coagulation Disorders (incl. Hemophilia)
- Hemophilia
- View All
Doctors Specialties
- Hematology
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Medical College of Wisconsin Affiliated Hospitals -
Medical College of Wisconsin
Hospital
-
Froedtert Memorial Lutheran Hospital -
Children's Hospital of Wisconsin
Helpful Reviews
Similar Doctors
|
Dr. Nathan J. Schloemer, MD
 This Doctor is OpenDoctor Recommended.
|
|
Debra J. Schmidt, APNP |
|
Dr. Meghen B. Browning, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sayed M. Hamadani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeanne Palmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prabhas Mittal, MD |
|
|
Dr. Sailaja C. Kamaraju, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marcio H. Malogolowkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Sup, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Vinitsky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Juanito P. Singson, MD |
|
|
Dr. Shamsuddin Virani, MD
This Doctor is OpenDoctor Recommended.
|